← Back to Screener
DaVita Inc. (DVA)
Price$192.16
Value ScoreC
Growth ScoreC
Momentum ScoreB
Favorite Metrics
Price vs S&P 500 (26W)52.64%
Price vs S&P 500 (4W)-3.26%
VGM Score59.80
Market Capitalization$12.34B
P/E Ratio (Annual)16.52x
All Metrics
P/CF (Annual)6.54x
Book Value / Share (Quarterly)$1.50
P/TBV (Annual)11.21x
Revenue Growth (3Y)5.53%
Cash Flow / Share (Quarterly)$22.55
Price vs S&P 500 (YTD)60.98%
Gross Margin (TTM)32.45%
Net Profit Margin (TTM)5.65%
EPS (TTM)$10.77
10-Day Avg Trading Volume0.71M
EPS Excl Extra (TTM)$10.77
Revenue Growth (5Y)3.39%
EPS (Annual)$9.84
ROI (Annual)9.79%
Gross Margin (Annual)32.25%
Net Profit Margin (5Y Avg)6.34%
Cash / Share (Quarterly)$10.07
P/E Basic Excl Extra (TTM)15.79x
Revenue Growth QoQ (YoY)5.96%
EPS Growth (5Y)9.36%
P/E Normalized (Annual)16.52x
ROA (Last FY)4.27%
Revenue Growth TTM (YoY)6.68%
EBITD / Share (TTM)$38.31
ROE (5Y Avg)220.50%
Operating Margin (TTM)14.98%
Cash Flow / Share (Annual)$19.12
P/B Ratio101.85x
P/B Ratio (Quarterly)101.25x
Net Income / Employee (Annual)$9,600
EV / Revenue (TTM)1.61x
Net Interest Coverage (TTM)3.46x
ROA (TTM)4.46%
EPS Growth QoQ (YoY)43.07%
EV / EBITDA (TTM)8.00x
EPS Incl Extra (Annual)$9.84
Current Ratio (Annual)1.29x
Quick Ratio (Quarterly)1.31x
3-Month Avg Trading Volume1.00M
52-Week Price Return39.51%
EV / Free Cash Flow (Annual)17.03x
P/E Incl Extra (TTM)15.79x
Revenue / Employee (TTM)$177,400
Tangible BV / Share (Quarterly)$2.29
P/S Ratio (Annual)0.90x
Asset Turnover (Annual)0.78x
52-Week High$202.69
Operating Margin (5Y Avg)14.24%
EPS Excl Extra (Annual)$9.84
CapEx CAGR (5Y)-3.11%
Tangible BV CAGR (5Y)-24.96%
26-Week Price Return60.56%
Quick Ratio (Annual)1.19x
13-Week Price Return28.16%
Total Debt / Equity (Annual)77.99x
Current Ratio (Quarterly)1.42x
Enterprise Value$22.32B
Revenue / Share Growth (5Y)13.87%
Asset Turnover (TTM)0.79x
Book Value / Share Growth (5Y)-38.38%
Revenue / Employee (Annual)$174,900
Inventory Turnover (Annual)62.63x
Pretax Margin (Annual)9.87%
Cash / Share (Annual)$10.22
3-Month Return Std Dev53.19%
Gross Margin (5Y Avg)31.46%
Net Income / Employee (TTM)$10,000
EBITDA CAGR (5Y)4.19%
EBITDA Interim CAGR (5Y)1.64%
ROE (Last FY)773.06%
Net Interest Coverage (Annual)3.53x
EPS Basic Excl Extra (Annual)$9.84
P/FCF (TTM)8.26x
Receivables Turnover (TTM)5.79x
EV / Free Cash Flow (TTM)14.95x
Total Debt / Equity (Quarterly)77.99x
EPS Incl Extra (TTM)$10.77
Receivables Turnover (Annual)5.37x
ROI (TTM)9.56%
P/S Ratio (TTM)0.89x
Pretax Margin (5Y Avg)10.58%
Revenue / Share (Annual)$179.79
Tangible BV / Share (Annual)$9.60
Forward P/E13.07x
Free OCF CAGR (5Y)0.09%
Price vs S&P 500 (52W)15.14%
P/E Ratio (TTM)15.79x
EPS Growth TTM (YoY)6.61%
Year-to-Date Return69.14%
5-Day Price Return1.24%
EPS Normalized (Annual)$9.84
ROA (5Y Avg)4.56%
Net Profit Margin (Annual)5.47%
Month-to-Date Return-1.13%
Cash Flow / Share (TTM)$17.04
EBITD / Share (Annual)$36.17
EPS Growth (3Y)19.05%
Operating Margin (Annual)14.88%
LT Debt / Equity (Annual)75.76x
P/CF (TTM)6.09x
ROI (5Y Avg)8.24%
P/E Excl Extra (TTM)15.79x
LT Debt / Equity (Quarterly)75.76x
EPS Basic Excl Extra (TTM)$10.77
P/TBV (Quarterly)71.72x
P/B Ratio (Annual)101.25x
Inventory Turnover (TTM)63.98x
Pretax Margin (TTM)10.13%
Book Value / Share (Annual)$1.50
Price vs S&P 500 (13W)19.90%
Net Margin Growth (5Y)-3.98%
Beta0.92x
P/FCF (Annual)9.41x
Revenue / Share (TTM)$200.87
ROE (TTM)181.22%
52-Week Low$101.00
vGradeC
gGradeC
mGradeB
vgmGradeC
Show chart for
Earnings Surprise History
Q1 262.87est. 2.34
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
2.65
3.36
3.43
3.43
Industry Peers — Health Services(17)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
DVADaVita Inc. | C | C | B | $192.16 |
| FMSFresenius Medical Care AG | A | D | C | $22.03 |
| SHCSotera Health Company Common Stock | D | B | C | $15.62 |
| PGNYProgyny, Inc. Common Stock | C | B | B | $25.86 |
| AGLagilon health, inc. | B | C | A | $96.85 |
| MCTACharming Medical Limited Class A Ordinary Shares | F | F | A | $29.36 |
| VMDViemed Healthcare, Inc. Common Shares | C | C | B | $9.97 |
| QIPTQuipt Home Medical Corp. Ordinary Shares | B | B | B | $0.00 |
| PARKPark Dental Partners, Inc. Common Stock | B | C | C | $18.96 |
| OAKUOak Woods Acquisition Corporation Class A Ordinary Shares | — | F | B | $0.00 |
| OAKUROak Woods Acquisition Corporation Right | — | F | B | $0.00 |
About
DaVita is the largest U.S. dialysis provider, operating over 3,000 facilities globally and treating approximately 280,000 patients annually, with roughly 35% of U.S. market share. The company derives about two-thirds of U.S. sales from government payers (primarily Medicare) at regulated reimbursement rates. Though commercial insurers represent only 10% of U.S. patients served, they generate nearly all profits from the U.S. dialysis business, creating significant earnings sensitivity to commercial payer mix.